secwatch / observer

Executive movement radar

Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.

Launch 76368 grounded facts newest September 3, 2026, 9:03 AM ET RSS · JSON

Showing 6901–6950 of 18650

Departed

Rudy C. Howard

Chief Financial Officer
Aravive, Inc.
Effective
2024-01-17
Filed
January 17, 2024, 6:59 PM ET
the Company terminated the employment of each of Gail McIntrye, Ph.D., the Company’s Chief Executive Officer and Rudy C. Howard, the Company’s Chief Financial Officer, effective as of January 17, 2024.
Departed

Gail McIntyre

Chief Executive Officer
Aravive, Inc.
Effective
2024-01-17
Filed
January 17, 2024, 6:59 PM ET
the Company terminated the employment of each of Gail McIntrye, Ph.D., the Company’s Chief Executive Officer and Rudy C. Howard, the Company’s Chief Financial Officer, effective as of January 17, 2024.
Departed

Yancey Spruill

Chief Executive Officer
DOCN · DigitalOcean Holdings, Inc.
Effective
2024-02-12
Successor
Padmanabhan Srinivasan
Filed
January 17, 2024, 6:59 PM ET
as of the Employment Date, Mr. Spruill will depart from the Company.
Appointed

Padmanabhan Srinivasan

Chief Executive Officer
DOCN · DigitalOcean Holdings, Inc.
Effective
2024-02-12
Filed
January 17, 2024, 6:59 PM ET
On January 11, 2024, DigitalOcean Holdings, Inc. (the “Company”) entered into an employment agreement with Padmanabhan Srinivasan (the “Srinivasan Agreement”) to serve as Chief Executive Officer of the Company, effective as of the commencement of his employment, which is currently expected to be on or around February 12, 2024 (the “Employment Date”).
Appointed (interim)

Stephen J. DiPalma

Treasurer and interim Chief Financial Officer
FHTX · Foghorn Therapeutics Inc.
Effective
2024-01-16
Filed
January 17, 2024, 6:59 PM ET
On January 16, 2024, the Board of Directors of Foghorn Therapeutics Inc. (the “Company”) appointed Stephen J. DiPalma as Treasurer and interim Chief Financial Officer (“CFO”), effective immediately.
Role change

Naiem Hussain

Chief Financial Officer
ADNH · ADVENT TECHNOLOGIES HOLDINGS, INC.
Effective
2024-01-10
Filed
January 17, 2024, 6:59 PM ET
On January 10, 2024, the Board of Directors of the Company (the “Board”) appointed Naiem Hussain, 56, the Company’s current Chief Investment Officer, to serve as Chief Financial Officer of the Company, pending the completion of the Company’s hiring protocols.
Departed

Carolina Dybeck Happe

Chief Financial Officer
GE · GENERAL ELECTRIC CO
Effective
2024-02-14
Filed
January 16, 2024, 6:59 PM ET
Ms. Dybeck Happe gave notice of her departure from GE effective February 14, 2024 due to her resignation for "Good Reason" as a result of the CFO transition.
Appointed

Marc Vandiepenbeeck

Executive Vice President and Chief Financial Officer
JCI · Johnson Controls International plc
Effective
2024-01-31
Filed
January 16, 2024, 6:59 PM ET
On January 16, 2024, the Company announced that Marc Vandiepenbeeck, the Company’s current Vice President and President, Building Solutions, Europe, Middle East, Africa and Latin America, will succeed Mr. Leonetti as the Company’s Executive Vice President and Chief Financial Officer and principal financial officer.
Departed

Olivier Leonetti

Executive Vice President and Chief Financial Officer
JCI · Johnson Controls International plc
Effective
2024-01-31
Successor
Marc Vandiepenbeeck
Filed
January 16, 2024, 6:59 PM ET
On January 9, 2024, Olivier Leonetti notified Johnson Controls International plc (the “Company”) of his intention to resign as the Company’s Executive Vice President and Chief Financial Officer and principal financial officer to take an executive role outside of the Company.
Departed

Allen Muhich

Chief Financial Officer
FARO TECHNOLOGIES INC
Effective
2024-01-16
Successor
Matthew Horwath
Filed
January 16, 2024, 6:59 PM ET
Mr. Horwath will succeed Allen Muhich, who will cease serving and depart as Chief Financial Officer effective as of the Effective Date.
Appointed

Dalip M. Puri

Executive Vice President and Chief Financial Officer
AME · AMETEK INC/
Effective
2024-04-02
Filed
January 16, 2024, 6:59 PM ET
The Company also announced that Dalip M. Puri was elected Executive Vice President and Chief Financial Officer of the Company effective April 2, 2024, assuming Mr. Burke’s position.
Departed

William J. Burke

Executive Vice President and Chief Financial Officer
AME · AMETEK INC/
Effective
2024-04-02
Successor
Dalip M. Puri
Filed
January 16, 2024, 6:59 PM ET
On January 16, 2024, AMETEK, Inc. (the “Company”) announced that William J. Burke, Executive Vice President and Chief Financial Officer, intends to retire effective April 2, 2024.
Departed

Robert Michael Dudley

President and Chief Executive Officer
RNAZ · Transcode Therapeutics, Inc.
Effective
2024-01-13
Successor
Thomas A. Fitzgerald
Filed
January 16, 2024, 6:59 PM ET
Robert Michael Dudley entered into a separation agreement with the Company pursuant to which he resigned from his position as the Company’s President and Chief Executive Officer, and as a director of the Company, in each case effective January 13, 2024.
Appointed (interim)

Thomas A. Fitzgerald

Interim President and Chief Executive Officer
RNAZ · Transcode Therapeutics, Inc.
Effective
2024-01-13
Filed
January 16, 2024, 6:59 PM ET
Thomas A. Fitzgerald, the Company’s Chief Financial Officer, was appointed to serve as the Company’s Interim President and Chief Executive Officer, effective January 13, 2024.
Departed

Kevin Crutchfield

President, Chief Executive Officer and member of the Board
CMP · COMPASS MINERALS INTERNATIONAL INC
Effective
2024-01-17
Successor
Edward C. Dowling Jr.
Filed
January 16, 2024, 6:59 PM ET
Mr. Crutchfield will cease to serve as President, Chief Executive Officer and as a member of the Board, effective January 17, 2024.
Appointed

Edward C. Dowling Jr.

President and Chief Executive Officer
CMP · COMPASS MINERALS INTERNATIONAL INC
Effective
2024-01-18
Filed
January 16, 2024, 6:59 PM ET
the Board appointed Edward C. Dowling, Jr. as the Company’s President and Chief Executive Officer, effective January 18, 2024
Departed

Yaron Garmazi

Chief Financial Officer
KLTR · KALTURA INC
Effective
2024-02-29
Successor
John Doherty
Filed
January 16, 2024, 6:59 PM ET
Yaron Garmazi, Chief Financial Officer of Kaltura, Inc. (the “ Company ”), notified the Company of his intention to resign from this position, effective February 29, 2024.
Appointed

John Doherty

Chief Financial Officer
KLTR · KALTURA INC
Effective
2024-03-01
Filed
January 16, 2024, 6:59 PM ET
the Board of Directors (the “ Board ”) of the Company appointed John Doherty as Chief Financial Officer of the Company, effective March 1, 2024
Appointed

Ben Errez

Chief Executive Officer
Coyni, Inc.
Effective
2023-04-24
Filed
January 16, 2024, 6:59 PM ET
On April 24, 2023, Ryvyl appointed Ben Errez, Ezra Laniado, and Genevieve Baer to the Board of Directors, and the directors proceeded to appoint Ben Errez and Jasmine Farrington as Chief Executive Officer and Secretary, respectively.
Departed

Cheng Yew Siong

Chief Financial Officer
Coyni, Inc.
Filed
January 16, 2024, 6:59 PM ET
The Chief Financial Officer and Principal Accounting Officer of the Company, Cheng Yew Siong, likewise resigned making the same representation as Mr. Han regarding no disagreements with the Company.
Role change (interim)

Jason Krantz

Interim Chief Executive Officer
DH · Definitive Healthcare Corp.
Effective
2024-01-16
Filed
January 16, 2024, 6:59 PM ET
On January 12, 2024, the Company’s Board of Directors appointed Jason Krantz, the Company’s founder and Executive Chairman, as Interim Chief Executive Officer, effective January 16, 2024.
Departed (interim)

Robert Musslewhite

Chief Executive Officer
DH · Definitive Healthcare Corp.
Effective
2024-01-16
Successor
Jason Krantz
Filed
January 16, 2024, 6:59 PM ET
On January 16, 2024, the Company announced that Robert Musslewhite has stepped down as the Company’s Chief Executive Officer and as a member of the Company’s Board of Directors, effective January 16, 2024
Role change

Christopher Peetz

Chief Executive Officer
MIRM · Mirum Pharmaceuticals, Inc.
Effective
2024-01-16
Successor
Peter Radovich
Filed
January 16, 2024, 6:59 PM ET
On January 11, 2024, the Board of Directors of Mirum Pharmaceuticals, Inc. (the “Company”) promoted Peter Radovich, previously the Company’s Chief Operating Officer, to the additional position of President, with Christopher Peetz, who previously served as the Company’s President and Chief Executive Officer, continuing to serve as the Company’s Chief Executive Officer, each effective as of January 16, 2024.
Departed

Joseph Frattaroli

Chief Financial Officer
IKT · Inhibikase Therapeutics, Inc.
Effective
2024-03-31
Successor
Garth Lees-Rolfe
Filed
January 16, 2024, 6:59 PM ET
Joseph Frattaroli provided notice to the Board of Directors (the “Board”) of Inhibikase Therapeutics, Inc. (the “Company”) of his intention to retire as Chief Financial Officer of the Company, effective at the end of the first quarter of 2024 or March 31, 2024.
Appointed

Garth Lees-Rolfe

Chief Financial Officer
IKT · Inhibikase Therapeutics, Inc.
Effective
2024-03-31
Filed
January 16, 2024, 6:59 PM ET
The Board will appoint Garth Lees-Rolfe to serve as Chief Financial Officer of the Company upon Mr. Frattaroli’s retirement and until the earliest of his removal, termination, or resignation from such office.
Appointed

Mallorie Burak

Chief Financial Officer
WATT · Energous Corp
Effective
2024-01-15
Filed
January 16, 2024, 6:59 PM ET
the Company announced that the board of directors (the “Board”) of the Company appointed Mallorie Burak as the Company’s Chief Financial Officer, effective as of the Effective Date.
Departed (interim)

Susan Kim van-Dongen

Interim Chief Financial Officer
WATT · Energous Corp
Effective
2024-01-15
Successor
Mallorie Burak
Filed
January 16, 2024, 6:59 PM ET
Effective as of January 15, 2024 (the “Effective Date”), Susan Kim van-Dongen no longer serves as Interim Chief Financial Officer of Energous Corporation (the “Company”).
Departed

Kiki Benson

Chief Financial Officer
MGAM · Mobile Global Esports, Inc.
Effective
2024-01-11
Successor
Mark J. Keeley
Filed
January 16, 2024, 6:59 PM ET
On January 11, 2024, Kiki Benson, the CFO of the Company, resigned as CFO, effective immediately.
Appointed

Mark J. Keeley

Chief Financial Officer
MGAM · Mobile Global Esports, Inc.
Effective
2024-01-11
Filed
January 16, 2024, 6:59 PM ET
On January 11, 2024, the Board of Directors of the Company appointed Mark J. Keeley as Chief Financial Officer of the Company on a consultancy basis.
Departed

Andrei Floroiu

President, Chief Executive Officer and Member of the Board of Directors
VXRT · Vaxart, Inc.
Effective
2024-01-15
Filed
January 16, 2024, 6:59 PM ET
On January 15, 2024 (the “Separation Date”), Andrei Floroiu resigned (i) as President and Chief Executive Officer of the Company, and (ii) as a member of the Company’s Board of Directors
Appointed (interim)

Michael J. Finney

Interim Chief Executive Officer
VXRT · Vaxart, Inc.
Effective
2024-01-16
Filed
January 16, 2024, 6:59 PM ET
On January 16, 2024, the Board announced that, effective as of January 16, 2024, the current Chair of the Board, Michael J. Finney, Ph.D, has been appointed as Interim Chief Executive Officer of the Company.
Departed

Chris Coulter

Chief Financial Officer
BOF · BranchOut Food Inc.
Effective
2024-01-10
Successor
John Dalfonsi
Filed
January 16, 2024, 6:59 PM ET
On January 10, 2024, Chris Coulter resigned as the Company’s Chief Financial Officer.
Appointed

John Dalfonsi

Chief Financial Officer
BOF · BranchOut Food Inc.
Effective
2024-01-10
Filed
January 16, 2024, 6:59 PM ET
On January 10, 2024, John Dalfonsi resigned as a member of the Company’s Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee, and was appointed to serve as the Company’s Chief Financial Officer.
Departed

Zahed Subhan

Chief Executive Officer
Adhera Therapeutics, Inc.
Effective
2024-01-12
Filed
January 16, 2024, 6:59 PM ET
on January 12, 2024, the Company received notice from Zahed Subhan that he was resigning as the Company’s Chief Executive Officer and as a member of the Company’s Board of Directors.
Departed

Nelson W. Grist

CEO
Perk International Inc.
Effective
2024-01-16
Filed
January 16, 2024, 6:59 PM ET
Effective JANUARY 16, 2024, NELSON W. GRIST resigned as a Director, Officer and CE0 of PERK INTERNATIONAL, INC.
Departed

Wm. Barrett Wellman

Chief Financial Officer
CJAX · CoJax Oil & Gas Corp
Effective
2024-01-10
Successor
Jeffrey J. Guzy
Filed
January 16, 2024, 6:59 PM ET
Effective as of January 10, 2024, Wm. Barrett Wellman resigned from his positions as Chief Financial Officer and Secretary of CoJax Oil and Gas Corporation, a Virginia corporation (the “Company”).
Appointed

William R. Downs

Chief Executive Officer
CJAX · CoJax Oil & Gas Corp
Effective
2024-01-10
Filed
January 16, 2024, 6:59 PM ET
effective immediately upon Mr. Guzy’s resignation from positions as Chief Executive Officer, Chairman of the Board and President, the Board appointed William R. Downs as Chief Executive Officer, President, and Chairman.
Departed

Jeffrey J. Guzy

Chief Executive Officer
CJAX · CoJax Oil & Gas Corp
Effective
2024-01-10
Successor
William R. Downs
Filed
January 16, 2024, 6:59 PM ET
On January 10, 2024, Mr. Guzy resigned from Chief Executive Officer, President and Chairman of the Board positions.
Appointed

Jeffrey J. Guzy

Chief Financial Officer
CJAX · CoJax Oil & Gas Corp
Effective
2024-01-10
Filed
January 16, 2024, 6:59 PM ET
Effective immediately upon Mr. Wellman’s resignation, the board of directors of the Company (the “Board”) appointed Jeffrey J. Guzy as the Company’s Chief Financial Officer, Secretary and Treasurer.
Appointed

Jason Bovell

Chief Financial Officer
AGSS · AMERIGUARD SECURITY SERVICES, INC.
Effective
2023-12-07
Filed
January 16, 2024, 6:59 PM ET
On December 7, 2023, the Board of Directors of AGSS resolved to appoint Jason Bovell as the Chief Financial Officer of AGSS and reassign Mike Goossen from Chief Financial Officer to Senior Controller.
Departed

Jason A. Amello

Chief Financial Officer
CADL · Candel Therapeutics, Inc.
Effective
2024-01-12
Successor
Charles Schoch
Filed
January 12, 2024, 6:59 PM ET
Jason A. Amello resigned from his position as the Chief Financial Officer, principal financial officer and principal accounting officer of the Company, effective January 12, 2024, to pursue another opportunity.
Appointed (interim)

Charles Schoch

interim Chief Financial Officer
CADL · Candel Therapeutics, Inc.
Effective
2024-01-12
Filed
January 12, 2024, 6:59 PM ET
unanimously appointed Charles Schoch as the Company’s interim Chief Financial Officer, principal financial officer and principal accounting officer, effective January 12, 2024.
Departed

David A. Johnson

Chief Financial Officer
MTEX · MANNATECH INC
Effective
2024-01-22
Successor
Landen Fredrick
Filed
January 12, 2024, 6:59 PM ET
On January 8, 2024, Mannatech, Incorporated (the "Company") and its Board of Directors (the "Board") were notified by David A. Johnson, the Company's Chief Financial Officer ("CFO"), of his resignation from his position effective January 22, 2024.
Appointed (interim)

Landen Fredrick

Chief Financial Officer
MTEX · MANNATECH INC
Filed
January 12, 2024, 6:59 PM ET
Landen Fredrick, the Company’s President and Chief Operating Officer, will serve as the CFO until such time as a permanent CFO is hired by the Company.
Departed

Mallorie Burak

President and Chief Financial Officer
KSCP · Knightscope, Inc.
Effective
2024-01-11
Successor
Apoorv S. Dwivedi
Filed
January 12, 2024, 6:59 PM ET
Mallorie Burak, President and Chief Financial Officer of the Company and its principal financial officer and principal accounting officer, resigned from her positions at the Company to pursue another professional opportunity, effective as of January 11, 2024
Appointed

Apoorv S. Dwivedi

Executive Vice President and Chief Financial Officer
KSCP · Knightscope, Inc.
Effective
2024-01-11
Filed
January 12, 2024, 6:59 PM ET
appointed Apoorv S. Dwivedi, 43, as the Executive Vice President and Chief Financial Officer
Appointed (interim)

Carmelo Carrubba

Interim Chief Financial Officer
BEACON ROOFING SUPPLY INC
Effective
2024-01-20
Filed
January 12, 2024, 6:59 PM ET
On January 8, 2024, Beacon Roofing Supply, Inc. (the “ Company ”) appointed Carmelo Carrubba, age 53, as the Company’s Interim Chief Financial Officer to be effective as of January 20, 2024, until a permanent CFO has been appointed.
Departed

Frank A. Lonegro

Executive Vice President and Chief Financial Officer
BEACON ROOFING SUPPLY INC
Effective
2024-02-01
Successor
Carmelo Carrubba
Filed
January 12, 2024, 6:59 PM ET
As previously disclosed on a Form 8-K filed with the Securities and Exchange Commission on December 4, 2023, the Company announced the resignation of Frank A. Lonegro as the Company’s Executive Vice President and Chief Financial Officer, effective as of February 1, 2024.
Appointed

Robert E. Claypoole

President and Chief Executive Officer
BVS · Bioventus Inc.
Effective
2024-01-10
Filed
January 12, 2024, 6:59 PM ET
As previously reported, Robert E. Claypoole succeeded Mr. Bihl as President and Chief Executive Officer of the Company on January 10, 2024.
Departed

Anthony P. Bihl III

Interim President and Chief Executive Officer
BVS · Bioventus Inc.
Effective
2024-01-10
Successor
Robert E. Claypoole
Filed
January 12, 2024, 6:59 PM ET
As previously reported, Robert E. Claypoole succeeded Mr. Bihl as President and Chief Executive Officer of the Company on January 10, 2024.

Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.